
    
      The study will compare different features of the Phonak behind the ear device activated and
      deactivated, for example the noise reduction feature. There shall be differences in listening
      effort, awareness and sound quality shown. The study shall show the advantages especially for
      people with severe to profound hearing losses. This will be a clinical investigation which
      will be conducted mono centric at Sonova AG Headquarters based in St√§fa (Switzerland).
    
  